St. Johns Investment Management’s Novo Nordisk NVO Stock Holding History

St. Johns Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82K	Hold	38	–	–	﹤0.01%	180
2026 Q1	$1.4K	Hold	38	–	–	﹤0.01%	181
2025 Q4	$1.93K	Hold	38	–	–	﹤0.01%	171
2025 Q3	$2.11K	Hold	38	–	–	﹤0.01%	172
2025 Q2	$2.62K	Hold	38	–	–	﹤0.01%	163
2025 Q1	$2.64K	Hold	38	–	–	﹤0.01%	150
2024 Q4	$3.27K	Hold	38	–	–	﹤0.01%	153
2024 Q3	$4.53K	Hold	38	–	–	﹤0.01%	161
2024 Q2	$5.42K	Hold	38	–	–	﹤0.01%	140
2024 Q1	$4.88K	Buy	+38	New	+$4.52K	﹤0.01%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

St. Johns Investment Management's NVO Position: Q2 2026 in Review

St. Johns Investment Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 38 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

St. Johns Investment Management first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.42K in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

St. Johns Investment Management held 38 shares of Novo Nordisk worth $1.82K as of Q2 2026.
St. Johns Investment Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of St. Johns Investment Management's portfolio in Q2 2026, its #180 holding.
St. Johns Investment Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
St. Johns Investment Management's Novo Nordisk position peaked at $5.42K in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on St. Johns Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.